• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒的实验性延长可延长永生细胞与正常细胞杂交体的寿命。

Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.

作者信息

Wright W E, Brasiskyte D, Piatyszek M A, Shay J W

机构信息

University of Texas Southwestern Medical Center at Dallas, Department of Cell Biology and Neurosciences 75235-9039, USA.

出版信息

EMBO J. 1996 Apr 1;15(7):1734-41.

PMID:8612598
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC450086/
Abstract

Hybrids between immortal cells that express telomerase and normal cells that lack telomerase have a limited lifespan. We demonstrate that telomerase is repressed in such hybrids. Treatment of immortal human cell lines with certain oligonucleotides resulted in telomere elongation. We took advantage of this observation to test the hypothesis that elongation of telomeres would extend the lifespan of cells in culture. An immortal human cell line was treated with an oligonucleotide to lengthen its telomeres and then was fused with mortal cells. The lifespan of these hybrid cells was longer than that of the hybrids in which telomeres had not been elongated. These observations provide the first direct evidence supporting the hypothesis that telomere length determines proliferative capacity of human cells.

摘要

表达端粒酶的永生细胞与缺乏端粒酶的正常细胞之间的杂交细胞寿命有限。我们证明在这种杂交细胞中端粒酶受到抑制。用某些寡核苷酸处理永生人类细胞系会导致端粒延长。我们利用这一观察结果来检验端粒延长会延长培养细胞寿命这一假说。用一种寡核苷酸处理一个永生人类细胞系以延长其端粒,然后将其与 mortal 细胞融合。这些杂交细胞的寿命比端粒未延长的杂交细胞更长。这些观察结果提供了首个直接证据支持端粒长度决定人类细胞增殖能力这一假说。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/aded717db15c/emboj00007-0270-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/698ad35672b3/emboj00007-0267-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/93ebcee87397/emboj00007-0268-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/c43d5b0f83e2/emboj00007-0269-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/aded717db15c/emboj00007-0270-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/698ad35672b3/emboj00007-0267-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/93ebcee87397/emboj00007-0268-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/c43d5b0f83e2/emboj00007-0269-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87d1/450086/aded717db15c/emboj00007-0270-a.jpg

相似文献

1
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.端粒的实验性延长可延长永生细胞与正常细胞杂交体的寿命。
EMBO J. 1996 Apr 1;15(7):1734-41.
2
Repression of an alternative mechanism for lengthening of telomeres in somatic cell hybrids.体细胞杂种中端粒延长替代机制的抑制
Oncogene. 1999 Jun 3;18(22):3383-90. doi: 10.1038/sj.onc.1202752.
3
Multiple pathways to cellular senescence: role of telomerase repressors.细胞衰老的多种途径:端粒酶抑制因子的作用
Eur J Cancer. 1997 Apr;33(5):710-5. doi: 10.1016/S0959-8049(97)00090-7.
4
Maintenance of telomeres in SV40-transformed pre-immortal and immortal human fibroblasts.SV40转化的前永生化和永生化人成纤维细胞中端粒的维持
J Cell Physiol. 1996 Sep;168(3):727-36. doi: 10.1002/(SICI)1097-4652(199609)168:3<727::AID-JCP26>3.0.CO;2-U.
5
Telomerase activity in hybrids between telomerase-negative and telomerase-positive immortal human cells is repressed in the different complementation groups but not in the same complementation group of immortality.端粒酶阴性和端粒酶阳性的永生人类细胞之间的杂交细胞中的端粒酶活性在不同的互补组中受到抑制,但在相同的永生互补组中则不受抑制。
Mech Ageing Dev. 1999 Oct 22;110(3):175-93. doi: 10.1016/s0047-6374(99)00054-8.
6
Telomerase and cancer.端粒酶与癌症
Important Adv Oncol. 1996:57-67.
7
Restoration of the cellular senescence program and repression of telomerase by human chromosome 3.人类3号染色体对细胞衰老程序的恢复及端粒酶的抑制作用。
Jpn J Cancer Res. 1995 Oct;86(10):899-904. doi: 10.1111/j.1349-7006.1995.tb02998.x.
8
A repressor function for telomerase activity in telomerase-negative immortal cells.端粒酶阴性永生化细胞中端粒酶活性的阻遏功能。
Mol Carcinog. 1998 Jan;21(1):17-25. doi: 10.1002/(sici)1098-2744(199801)21:1<17::aid-mc4>3.0.co;2-m.
9
Telomere elongation in immortal human cells without detectable telomerase activity.在无可检测到的端粒酶活性的永生人类细胞中端粒延长。
EMBO J. 1995 Sep 1;14(17):4240-8. doi: 10.1002/j.1460-2075.1995.tb00098.x.
10
Hallmarks of telomeres in ageing research.衰老研究中端粒的特征。
J Pathol. 2007 Jan;211(2):114-23. doi: 10.1002/path.2090.

引用本文的文献

1
Telomeres control human telomerase () expression through non-telomeric TRF2.端粒通过非端粒的TRF2控制人类端粒酶的表达。
Elife. 2025 Sep 30;14:RP104045. doi: 10.7554/eLife.104045.
2
Telomere length sensitive regulation of interleukin receptor 1 type 1 (IL1R1) by the shelterin protein TRF2 modulates immune signalling in the tumour microenvironment.端粒长度通过保护蛋白TRF2对白细胞介素1受体1型(IL1R1)进行敏感调节,从而调控肿瘤微环境中的免疫信号传导。
Elife. 2024 Dec 27;13:RP95106. doi: 10.7554/eLife.95106.
3
Thiourea-functionalized aminoglutethimide derivatives as anti-leishmanial agents.

本文引用的文献

1
Telomerase activity in human cancer.人类癌症中的端粒酶活性
Curr Opin Oncol. 1996 Jan;8(1):66-71. doi: 10.1097/00001622-199601000-00012.
2
Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes.正常及21三体人类淋巴细胞衰老过程中端粒DNA的丢失。
Am J Hum Genet. 1993 Apr;52(4):661-7.
3
E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts.人乳头瘤病毒16型的E6蛋白能够使人类乳腺上皮细胞越过永生化的M1阶段,但无法作用于人类成纤维细胞。
硫脲功能化氨苯蝶啶衍生物作为抗利什曼原虫药物。
Future Med Chem. 2024 Aug 2;16(15):1485-1497. doi: 10.1080/17568919.2024.2359362. Epub 2024 Jul 2.
4
Transcription stress at telomeres leads to cytosolic DNA release and paracrine senescence.端粒处的转录应激会导致细胞质 DNA 释放和旁分泌衰老。
Nat Commun. 2024 May 14;15(1):4061. doi: 10.1038/s41467-024-48443-6.
5
Analysis and pharmacological modulation of senescence in human epithelial stem cells.人类上皮干细胞衰老的分析和药理学调节。
J Cell Mol Med. 2022 Jul;26(14):3977-3994. doi: 10.1111/jcmm.17434. Epub 2022 Jun 15.
6
Enhanced Survival of High-Risk Medulloblastoma-Bearing Mice after Multimodal Treatment with Radiotherapy, Decitabine, and Abacavir.多模态治疗(放疗、地西他滨、阿巴卡韦)改善高危髓母细胞瘤荷瘤小鼠的生存。
Int J Mol Sci. 2022 Mar 30;23(7):3815. doi: 10.3390/ijms23073815.
7
Vegetables and Their Bioactive Compounds as Anti-Aging Drugs.蔬菜及其生物活性化合物作为抗衰老药物。
Molecules. 2022 Apr 2;27(7):2316. doi: 10.3390/molecules27072316.
8
Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential.端粒和端粒蛋白在人类恶性肿瘤中的作用及其治疗潜力
Cancers (Basel). 2020 Jul 14;12(7):1901. doi: 10.3390/cancers12071901.
9
The aging lysosome: An essential catalyst for late-onset neurodegenerative diseases.衰老的溶酶体:晚期神经退行性疾病的必要催化剂。
Biochim Biophys Acta Proteins Proteom. 2020 Sep;1868(9):140443. doi: 10.1016/j.bbapap.2020.140443. Epub 2020 May 13.
10
Revisiting Telomere Shortening in Cancer.重新审视癌症中的端粒缩短。
Cells. 2019 Jan 31;8(2):107. doi: 10.3390/cells8020107.
Oncogene. 1993 Jun;8(6):1407-13.
4
RAP1 and telomere structure regulate telomere position effects in Saccharomyces cerevisiae.Rap1蛋白与端粒结构调控酿酒酵母中的端粒位置效应。
Genes Dev. 1993 Jul;7(7A):1146-59. doi: 10.1101/gad.7.7a.1146.
5
p21 is a universal inhibitor of cyclin kinases.p21是细胞周期蛋白激酶的通用抑制剂。
Nature. 1993 Dec 16;366(6456):701-4. doi: 10.1038/366701a0.
6
WAF1, a potential mediator of p53 tumor suppression.WAF1,一种p53肿瘤抑制的潜在介导因子。
Cell. 1993 Nov 19;75(4):817-25. doi: 10.1016/0092-8674(93)90500-p.
7
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.p21 Cdk相互作用蛋白Cip1是G1期细胞周期蛋白依赖性激酶的有效抑制剂。
Cell. 1993 Nov 19;75(4):805-16. doi: 10.1016/0092-8674(93)90499-g.
8
A conserved sequence motif within the exceptionally diverse telomeric sequences of budding yeasts.在出芽酵母异常多样的端粒序列中的一个保守序列基序。
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3453-7. doi: 10.1073/pnas.91.8.3453.
9
Telomerase activity in human ovarian carcinoma.人卵巢癌中的端粒酶活性
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):2900-4. doi: 10.1073/pnas.91.8.2900.
10
Assignment of two human epidermal squamous cell carcinomas cell lines to more than one complementation group for the immortal phenotype.将两个人表皮鳞状细胞癌细胞系归为不止一个永生表型互补组。
Mol Carcinog. 1994 Mar;9(3):134-42. doi: 10.1002/mc.2940090305.